相关实验视频
Updated: Jul 12, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
针对BRAF-突变黑色素瘤的个性化治疗的进展和挑战:全面审查
Abdulaziz Shebrain1, Omer A Idris1,2, Ali Jawad1
1Department of Biological Sciences, Western Michigan University, Kalamazoo, MI 49008, USA.
Journal of clinical medicine
|September 28, 2024
概括
先进的黑色素瘤治疗方法面临着瘤微环境带来的挑战. 瘤透淋巴细胞 (TIL) 疗法对BRAF突变黑色素瘤具有前景,生物标志物有助于个性化免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 黑色素瘤研究 黑色素瘤研究
背景情况:
- 黑色素瘤治疗已经通过向疗法 (BRAF抑制剂) 和免疫疗法 (抗PD-1,抗CTLA4) 进化.
- 瘤微环境的复杂性和免疫逃避机制有助于治疗耐药性.
- 个性化医学旨在量身定制治疗,但瘤异质性带来了挑战.
研究的目的:
- 审查BRAF突变黑色素瘤治疗的当前进展.
- 突出瘤微环境和免疫逃避所带来的挑战.
- 讨论瘤透淋巴细胞 (TIL) 治疗和早期反应生物标志物的潜力.
主要方法:
- 对BRAF突变黑色素瘤治疗现有文献的综述.
- 分析瘤微环境在治疗耐药性的作用.
- 评估TIL治疗 (lifileucel) 和生物标志物 (COX-2,MMP2,FDG-PET) 的疗效和潜力.
主要成果:
- 向疗法和免疫疗法显示出有效性,但面临抗药性.
- 以lifileucel为例的TIL疗法在BRAF V600突变黑色素瘤中表现出显著的疗效.
- 早期反应生物标志物和成像可以潜在地预测患者的反应并优化治疗.
结论:
- 尽管存在挑战,但TIL疗法为BRAF突变黑色素瘤提供了一个有希望的途径.
- 生物标志物和成像对于增强个性化免疫疗法至关重要.
- 减少TIL治疗的收获时间和成本对于更广泛的可访问性至关重要.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

